Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis
- PMID: 19002078
- PMCID: PMC6245429
- DOI: 10.3390/molecules13112758
Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis
Abstract
Polyanionic macromolecules are extremely abundant both in the extracellular environment and inside the cell, where they are readily accessible to many proteins for interactions that play a variety of biological roles. Among polyanions, heparin, heparan sulfate proteoglycans (HSPGs) and glycosphingolipids (GSLs) are widely distributed in biological fluids, at the cell membrane and inside the cell, where they are implicated in several physiological and/or pathological processes such as infectious diseases, angiogenesis and tumor growth. At a molecular level, these processes are mainly mediated by microbial proteins, cytokines and receptors that exert their functions by binding to HSPGs and/or GSLs, suggesting the possibility to use polyanionic antagonists as efficient drugs for the treatment of infectious diseases and cancer. Polysulfated (PS) or polysulfonated (PSN) compounds are a heterogeneous group of natural, semi-synthetic or synthetic molecules whose prototypes are heparin and suramin. Different structural features confer to PS/PSN compounds the capacity to bind and inhibit the biological activities of those same heparin-binding proteins implicated in infectious diseases and cancer. In this review we will discuss the state of the art and the possible future development of polyanionic drugs in the treatment of infectious diseases and cancer.
Figures





Similar articles
-
Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis.Curr Pharm Des. 2009;15(25):2946-57. doi: 10.2174/138161209789058156. Curr Pharm Des. 2009. PMID: 19754371 Review.
-
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.Molecules. 2015 Apr 10;20(4):6342-88. doi: 10.3390/molecules20046342. Molecules. 2015. PMID: 25867824 Free PMC article. Review.
-
Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides.Pharmacol Ther. 2009 Sep;123(3):310-22. doi: 10.1016/j.pharmthera.2009.05.001. Epub 2009 May 14. Pharmacol Ther. 2009. PMID: 19447134 Review.
-
Metalloglycomics.Met Ions Life Sci. 2018 Feb 5;18:/books/9783110470734/9783110470734-007/9783110470734-010.xml. doi: 10.1515/9783110470734-010. Met Ions Life Sci. 2018. PMID: 29394023 Review.
-
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.Antimicrob Agents Chemother. 2007 Jul;51(7):2337-45. doi: 10.1128/AAC.01362-06. Epub 2007 Apr 23. Antimicrob Agents Chemother. 2007. PMID: 17452490 Free PMC article.
Cited by
-
Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition.Front Immunol. 2013 Nov 20;4:385. doi: 10.3389/fimmu.2013.00385. Front Immunol. 2013. PMID: 24312095 Free PMC article. Review.
-
Heparan sulfate-dependent enhancement of henipavirus infection.mBio. 2015 Mar 10;6(2):e02427. doi: 10.1128/mBio.02427-14. mBio. 2015. PMID: 25759505 Free PMC article.
-
Circulating Fibroblast Growth Factor-2, HIV-Tat, and Vascular Endothelial Cell Growth Factor-A in HIV-Infected Children with Renal Disease Activate Rho-A and Src in Cultured Renal Endothelial Cells.PLoS One. 2016 Apr 20;11(4):e0153837. doi: 10.1371/journal.pone.0153837. eCollection 2016. PLoS One. 2016. PMID: 27097314 Free PMC article.
-
Smart and Biomimetic 3D and 4D Printed Composite Hydrogels: Opportunities for Different Biomedical Applications.Biomedicines. 2021 Oct 26;9(11):1537. doi: 10.3390/biomedicines9111537. Biomedicines. 2021. PMID: 34829766 Free PMC article. Review.
-
Monoclonal antibody against EV71 3Dpol inhibits the polymerase activity of RdRp and virus replication.BMC Immunol. 2019 Jan 22;20(1):6. doi: 10.1186/s12865-019-0288-x. BMC Immunol. 2019. PMID: 30669993 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases